Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Huntingtonon Feb 03, 2018 12:39pm
134 Views
Post# 27496629

RE:If Apple were valued at the same multiple to earnings as ACB

RE:If Apple were valued at the same multiple to earnings as ACBWhat you are saying is true but you are misleading when you are failing to take into account future earnings.  I don’t believe you are that short sighted or ignorant just misleading to fill your own needs. Also over a fifth of Apples cash reserves come from tax avoidance, really legalized tax cheating.  Also remind me how apple is losing market share quickly. I’m not saying apple has been a bad investment with its four stock splits (45 shares grew to 2500) As I’ve  stated before even with ACB gaining a conservative 20% market share of a $5.5B industry, they would generate $1.1B at home not to mention there expanding global networks and licensing of patents. Even at a share price of $15 the market cap of $6.8B looks good in contrast to $1.1B in annual revenue.  Please stick to the facts and stop comparing some of the worlds most valuable and successfull companies to an emerging industry.  It’s not clever at all.
Bullboard Posts